• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】30994

【品名】3-bromopropyl tert-butyl(dimethyl)silyl ether; (3-bromopropoxy)(tert-butyl)dimethylsilane

【CA登记号】

【 分 子 式 】C9H21BrOSi

【 分 子 量 】253.25464

【元素组成】C 42.68% H 8.36% Br 31.55% O 6.32% Si 11.09%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(II)

The intermediate 1-(4-fluorophenyl)-1-(3-hydroxypropyl)-1,3-dihydroisobenzofuran-5-carbonitrile (IV) has been obtained by three related ways: 1. The condensation of 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (I) with 3-(tert-butyldimethylsilyloxy)propyl bromide (II) by means of LDA in THF gives 1-[3-(tert-butyldimethylsilyloxy)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (III), which is deprotected with HCl in methanol to yield the hydroxypropyl intermediate (IV). 2. The condensation of 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (I) with 3-(benzyloxy)propyl bromide (V) by means of LDA in THF gives 1-[3-(benzyloxy)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (VI), which is deprotected by treatment with 1,4-cyclohexadiene over Pd/C in ethanol to yield the hydroxypropyl intermediate (IV). 3. The condensation of 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (I) with 3-(tetrahydropyranyloxy)propyl bromide (VII) by means of LDA in THF gives 1-(4-fluorophenyl)-1-[3-(tetrahydropyranyloxy)propyl]-1,3-dihydroisobenzofuran-5-carbonitrile (VIII), which is deprotected with Ts-OH in methanol to yield the hydroxypropyl intermediate (IV). The reaction of the intermediate (IV) with Ts-Cl and TEA in toluene gives the corresponding tosylate (IX), which is finally treated with dimethylamine in hot DMF to afford the target citalopram. The reaction of the intermediate (IV) with Ms-Cl and TEA in THF gives the corresponding mesylate (X), which is finally treated with dimethylamine in hot ethanol/THF to afford the target citalopram. Alternatively, the reaction of mesylate (X) with NaN3 in hot DMF gives the corresponding azido compound (XI), which is hydrogenated with H2 over Pd/C in EtOH to yield the 3-aminopropyl derivative (XII). Finally, this compound is methylated by means of formaldehyde and NaCNBH3 in methanol to provide the target citalopram.

1 Petersen, H.; Rock, M.H.; Ahmadian, H. (H. Lundbeck A/S); Method for the preparation of citalopram. US 6420574 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 33233 1-(4-fluorophenyl)-5-phtalancarbonitrile; 1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile C15H10FNO 详情 详情
(II) 30994 3-bromopropyl tert-butyl(dimethyl)silyl ether; (3-bromopropoxy)(tert-butyl)dimethylsilane C9H21BrOSi 详情 详情
(III) 55297 1-(3-{[tert-butyl(dimethyl)silyl]oxy}propyl)-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile C24H30FNO2Si 详情 详情
(IV) 55298 1-(4-fluorophenyl)-1-(3-hydroxypropyl)-1,3-dihydro-2-benzofuran-5-carbonitrile C18H16FNO2 详情 详情
(V) 28080 1-[(3-bromopropoxy)methyl]benzene C10H13BrO 详情 详情
(VI) 55299 1-[3-(benzyloxy)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile C25H22FNO2 详情 详情
(VII) 42252 3-bromopropyl tetrahydro-2H-pyran-2-yl ether; 2-(3-bromopropoxy)tetrahydro-2H-pyran C8H15BrO2 详情 详情
(VIII) 55300 1-(4-fluorophenyl)-1-[3-(tetrahydro-2H-pyran-2-yloxy)propyl]-1,3-dihydro-2-benzofuran-5-carbonitrile C23H24FNO3 详情 详情
(IX) 55301 3-[5-cyano-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-1-yl]propyl 4-methylbenzenesulfonate C25H22FNO4S 详情 详情
(X) 55302 3-[5-cyano-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-1-yl]propyl methanesulfonate C19H18FNO4S 详情 详情
(XI) 55303 1-(3-azidopropyl)-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile C18H15FN4O 详情 详情
(XII) 55304 1-(3-aminopropyl)-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile C18H17FN2O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

The reaction of 3-bromopropanol (I) with TBDMS-Cl, DIEA and DMAP in dichloromethane gives the silyl ether (II), which is treated with PPh3 in refluxing acetonitrile yielding the phosphonium salt (III). The Wittig reaction of (III) with 3-cholestanone (IV) by means of BuLi in DME affords 3-[3-(tert-butyldimethylsilyloxy)propylidene]cholestane (V), which is reduced with H2 over PtO2 in ethyl acetate giving 3beta-[3-(tert-butyldimethylsilyloxy)propyl]cholestane (VI). The reaction of (VI) with TBAF in THF gives the 3-hydroxypropyl derivative (VII), which is treated with CBr4 and PPh3 in dichloromethane yielding the 3-bromopropyl derivative (VIII). The reaction of (VIII) with PPh3 in refluxing chlorobenzene affords the phosphonium salt (IX), which is submitted to a Wittig condensation with 5,5'-carbonylbis(3-chloro-2-methoxybenzoic acid methyl ester) (X) by means of NaN(SiMe3)2 in THF giving the expected condensation intermediate (XI). The intermediate 5,5'-carbonylbis(3-chloro-2-methoxybenzoic acid methyl ester) (X) has been obtained as follows: The dimerization of 3-chloro-2-hydroxybenzoic acid (XII) with H2CO and H2SO4 in methanol gives 5,5'-methylenebis(3-chloro-2-hydroxybenzoic acid) (XIII), which is fully methylated with SO4Me2 or CO3Me2 and K2CO3 yielding 5,5'-methylenebis(3-chloro-2-methoxybenzoic acid methyl ester) (XIV). Finally, this compound is oxidized with CrO3 in acetic anhydride to afford the desired intermediate (X).

1 Bader, J.P.; Cushman, M.; Golebiewski, W.M.; Design and synthesis of cosalane, a novel anti-HIV agent. Bioorg Med Chem Lett 1993, 3, 8, 1739.
2 Golebiewski, W.M.; McMahon, J.B.; Cushman, M.; et al.; Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. J Med Chem 1994, 37, 19, 3040.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12573 3-Bromo-1-propanol; 3-Bromopropanol 627-18-9 C3H7BrO 详情 详情
(II) 30994 3-bromopropyl tert-butyl(dimethyl)silyl ether; (3-bromopropoxy)(tert-butyl)dimethylsilane C9H21BrOSi 详情 详情
(III) 30995 (3-[[tert-butyl(dimethyl)silyl]oxy]propyl)(triphenyl)phosphonium bromide C27H36BrOPSi 详情 详情
(IV) 30996 (10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one 15600-08-5 C27H46O 详情 详情
(V) 30997 tert-butyl(3-[(10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-ylidene]propoxy)dimethylsilane; tert-butyl(dimethyl)silyl 3-[(10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-ylidene]propyl ether C36H66OSi 详情 详情
(VI) 30998 tert-butyl(dimethyl)silyl 3-[(3R,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]propyl ether; tert-butyl(3-[(3R,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]propoxy)dimethylsilane C36H68OSi 详情 详情
(VII) 30999 3-[(3R,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]-1-propanol C30H54O 详情 详情
(VIII) 31000 (3R,10S,13R,17R)-3-(3-bromopropyl)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene C30H53Br 详情 详情
(IX) 31001 (3-[(3R,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]propyl)(trimethyl)phosphonium bromide C33H62BrP 详情 详情
(X) 26176 methyl 3-chloro-5-[3-chloro-4-methoxy-5-(methoxycarbonyl)benzoyl]-2-methoxybenzoate C19H16Cl2O7 详情 详情
(XI) 31002 methyl 3-chloro-5-(1-[3-chloro-4-methoxy-5-(methoxycarbonyl)phenyl]-4-[(3S,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]-1-butenyl)-2-methoxybenzoate C49H68Cl2O6 详情 详情
(XII) 31003 3-chloro-2-hydroxybenzoic acid C7H5ClO3 详情 详情
(XIII) 31004 5-(3-carboxy-5-chloro-4-hydroxybenzyl)-3-chloro-2-hydroxybenzoic acid C15H10Cl2O6 详情 详情
(XIV) 31005 methyl 3-chloro-5-[3-chloro-4-methoxy-5-(methoxycarbonyl)benzyl]-2-methoxybenzoate C19H18Cl2O6 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

The reaction of 3-bromopropanol (I) with TBDMS-Cl, DIEA and DMAP in dichloromethane gives the silyl ether (II), which is treated with PPh3 in refluxing acetonitrile yielding the phosphonium salt (III). The Wittig reaction of (III) with 3-cholestanone (IV) by means of BuLi in DME affords 3-[3-(tert-butyldimethylsilyloxy)propylidene]cholestane (V), which is reduced with H2 over PtO2 in ethyl acetate giving 3beta-[3-(tert-butyldimethylsilyloxy)propyl]cholestane (VI). The reaction of (VI) with TBAF in THF gives the 3-hydroxypropyl derivative (VII), which is treated with CBr4 and PPh3 in dichloromethane yielding the 3-bromopropyl derivative (VIII). The reaction of (VIII) with PPh3 in refluxing chlorobenzene affords the phosphonium salt (IX), which is submitted to a Wittig condensation with 5,5'-carbonylbis(3-chloro-2-methoxybenzoic acid methyl ester) (X) by means of NaN(SiMe3)2 in THF giving the expected condensation intermediate (XI). The intermediate 5,5'-carbonylbis(3-chloro-2-methoxybenzoic acid methyl ester) (X) has been obtained as follows: The dimerization of 3-chloro-2-hydroxybenzoic acid (XII) with H2CO and H2SO4 in methanol gives 5,5'-methylenebis(3-chloro-2-hydroxybenzoic acid) (XIII), which is fully methylated with SO4Me2 or CO3Me2 and K2CO3 yielding 5,5'-methylenebis(3-chloro-2-methoxy-benzoic acid methyl ester) (XIV). Finally, this compound is oxidized with CrO3 in acetic anhydride to afford the desired intermediate (X).

1 Golebiewski, W.M.; McMahon, J.B.; Cushman, M.; et al.; Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. J Med Chem 1994, 37, 19, 3040.
2 Bader, J.P.; Cushman, M.; Golebiewski, W.M.; Design and synthesis of cosalane, a novel anti-HIV agent. Bioorg Med Chem Lett 1993, 3, 8, 1739.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12573 3-Bromo-1-propanol; 3-Bromopropanol 627-18-9 C3H7BrO 详情 详情
(II) 30994 3-bromopropyl tert-butyl(dimethyl)silyl ether; (3-bromopropoxy)(tert-butyl)dimethylsilane C9H21BrOSi 详情 详情
(III) 30995 (3-[[tert-butyl(dimethyl)silyl]oxy]propyl)(triphenyl)phosphonium bromide C27H36BrOPSi 详情 详情
(IV) 30996 (10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one 15600-08-5 C27H46O 详情 详情
(V) 30997 tert-butyl(3-[(10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-ylidene]propoxy)dimethylsilane; tert-butyl(dimethyl)silyl 3-[(10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-ylidene]propyl ether C36H66OSi 详情 详情
(VI) 30998 tert-butyl(dimethyl)silyl 3-[(3R,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]propyl ether; tert-butyl(3-[(3R,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]propoxy)dimethylsilane C36H68OSi 详情 详情
(VII) 30999 3-[(3R,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]-1-propanol C30H54O 详情 详情
(VIII) 31000 (3R,10S,13R,17R)-3-(3-bromopropyl)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene C30H53Br 详情 详情
(IX) 31001 (3-[(3R,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]propyl)(trimethyl)phosphonium bromide C33H62BrP 详情 详情
(X) 26176 methyl 3-chloro-5-[3-chloro-4-methoxy-5-(methoxycarbonyl)benzoyl]-2-methoxybenzoate C19H16Cl2O7 详情 详情
(XI) 31002 methyl 3-chloro-5-(1-[3-chloro-4-methoxy-5-(methoxycarbonyl)phenyl]-4-[(3S,10S,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl]-1-butenyl)-2-methoxybenzoate C49H68Cl2O6 详情 详情
(XII) 31003 3-chloro-2-hydroxybenzoic acid C7H5ClO3 详情 详情
(XIII) 31004 5-(3-carboxy-5-chloro-4-hydroxybenzyl)-3-chloro-2-hydroxybenzoic acid C15H10Cl2O6 详情 详情
(XIV) 31005 methyl 3-chloro-5-[3-chloro-4-methoxy-5-(methoxycarbonyl)benzyl]-2-methoxybenzoate C19H18Cl2O6 详情 详情

合成路线4

该中间体在本合成路线中的序号:(X)

An alternative procedure for the synthesis of indolylpropanol (VII) is depicted as follows: alkylation of 2-trimethylsilyl-1,3-dithiane (IX) with bromide (X) employing n-butyllithium in cold THF afforded (XI). Subsequent hydrolysis of the thioacetal group of (XI) by means of HgO/HgCl2 provided acylsilane (XII). Iodoaniline (XIII) was prepared by iodination of p-triazolylaniline (IV) with iodine monochloride. Condensation of iodoaniline (XIII) with acylsilane (XII) in the presence of Pd(OAc)2 produced the silylated indole (XIV). Then acid treatment of (XIV) removed both silyl groups to give (VII).

1 Baker, R.; Bourrain, S.; Castro Pineiro, J.L.; Chambers, M.S.; Guiblin, A.R.; Hobbs, S.C.; Jelley, R.A.; Madin, A.; Matassa, V.G.; Reeve, A.J.; Russell, M.G.N.; Showell, G.A.; Sternfeld, F.; Street, L.J.; Van Niel, M.B. (Merck Sharp & Dohme Ltd.); Azetidine, pyrrolidine and piperidine derivs.. EP 0804434; JP 1998503768; US 5854268; WO 9604274 .
2 Chen, C.-Y.; Larsen, R.D. (Merck & Co., Inc.); Palladium catalyzed indolization. US 5808064; WO 9806725 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 36537 4-(4H-1,2,4-triazol-4-yl)phenylamine; 4-(4H-1,2,4-triazol-4-yl)aniline C8H8N4 详情 详情
(VII) 36538 3-[5-(4H-1,2,4-triazol-4-yl)-1H-indol-3-yl]-1-propanol C13H14N4O 详情 详情
(IX) 16517 1,3-dithian-2-yl(trimethyl)silane; 2-Trimethylsilyl-1,3-dithiane 13411-42-2 C7H16S2Si 详情 详情
(X) 30994 3-bromopropyl tert-butyl(dimethyl)silyl ether; (3-bromopropoxy)(tert-butyl)dimethylsilane C9H21BrOSi 详情 详情
(XI) 36540 tert-butyl(dimethyl)[3-[2-(trimethylsilyl)-1,3-dithian-2-yl]propoxy]silane; tert-butyl(dimethyl)silyl 3-[2-(trimethylsilyl)-1,3-dithian-2-yl]propyl ether C16H36OS2Si2 详情 详情
(XII) 36541 4-[[tert-butyl(dimethyl)silyl]oxy]-1-(trimethylsilyl)-1-butanone C13H30O2Si2 详情 详情
(XIII) 36542 2-iodo-4-(4H-1,2,4-triazol-4-yl)aniline; 2-iodo-4-(4H-1,2,4-triazol-4-yl)phenylamine C8H7IN4 详情 详情
(XIV) 36543 3-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-5-(4H-1,2,4-triazol-4-yl)-2-(trimethylsilyl)-1H-indole; tert-butyl(dimethyl)silyl 3-[5-(4H-1,2,4-triazol-4-yl)-2-(trimethylsilyl)-1H-indol-3-yl]propyl ether C22H36N4OSi2 详情 详情
Extended Information